Renflexis 100 MG vials
Ended Awarded
- Contract number
- SPE2DB26FP7JQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,366
Award facts
- Contract value 100% obligated
- $2,365.62 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Renflexis 100 mg vials under a firm fixed price contract. The award, issued on November 4, 2025, has a ceiling value of $2,365.62 and an ultimate completion date of November 5, 2025. This is a non-set-aside competitive award with performance to be executed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
Renflexis is a biosimilar to Remicade used in the treatment of inflammatory conditions including rheumatoid arthritis, Crohn's disease, and ulcerative colitis. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through its extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies. The firm fixed price delivery order structure is consistent with AmerisourceBergen's typical federal contracting approach, which demonstrates the company's capability to meet varied federal medical supply requirements through open competition.
Quick answers
Who was awarded contract SPE2DB26FP7JQ?
SPE2DB26FP7JQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 4, 2025.
How much is contract SPE2DB26FP7JQ worth?
The government has obligated $2,366 on SPE2DB26FP7JQ.
Is contract SPE2DB26FP7JQ an order under another contract?
Yes. SPE2DB26FP7JQ is a delivery order under SPE2DB22D3011, an indefinite delivery contract.
Was contract SPE2DB26FP7JQ competed?
The extent of competition for SPE2DB26FP7JQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award